(OKRA) Evaluation of Patient Outcomes From the Kidney Allograft Outcomes Allosure Registry
This study is a registry rather than a treatment study. It will follow patients who have kidney transplants. It will compare different methods of monitoring transplant rejection.
1. Medicare Part B covered renal transplant recipients selected by their providers to receive AlloSure
testing as part of their practical care beginning by 2 months post-transplantation.
2. A patient whose health care provider adopts and intends to apply the center?s AlloSure Routine Testing SN-C-00010 - 14 - Confidential and Proprietary Schedule as part of the information used to manage the patient.